Melanoma - United States Market and Competitive Landscape (2018-2023) - ResearchAndMarkets.com

October 12, 2018

DUBLIN--(BUSINESS WIRE)--Oct 12, 2018--The “US Melanoma Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

This report provides comprehensive insights into Melanoma pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares.

The study accurately estimates and forecast Melanoma market size and drug sales. This research also provides insights into Melanoma epidemiology and late stage pipeline.

The research is classified into following sections - Melanoma overview with definitions, symptoms, etiology, diagnosis, treatment options; Melanoma pipeline insights covering late stage clinical trials pipeline; Melanoma prevalence trends by countries; Melanoma market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.

Research Scope

Melanoma pipeline: Find out the drugs in clinical trials for Melanoma by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company Melanoma epidemiology: Find out the prevalence of Melanoma in US; prevalence forecast to 2023 Melanoma products: Identify key products marketed and prescribed for Melanoma by brand name, by molecule, by company, by branded / generic, in US Melanoma market size: Find out the market size for Melanoma drugs in US; Find out how the market advanced from 2014 Melanoma drug sales: Find out the sales of Melanoma drugs in US Melanoma drugs sales forecast: Sales forecast for Melanoma drugs to 2023 in US Melanoma market share analysis: Find out the market shares of Melanoma drugs and outlook in US

For more information about this report visit https://www.researchandmarkets.com/research/snnrns/melanoma_united?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181012005253/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Skin Cancer Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/12/2018 09:36 AM/DISC: 10/12/2018 09:36 AM


Update hourly